{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:05:38Z","timestamp":1747166738353,"version":"3.40.5"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.lanwpc.2022.100522","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T02:17:04Z","timestamp":1657160224000},"page":"100522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6032-1469","authenticated-orcid":false,"given":"Alice","family":"Minhinnick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyu Sin","family":"Aye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Mark","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark James","family":"McKeage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2022.100522_bib0001","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0002","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1055-9965.EPI-20-1702","article-title":"The evolving epidemiology of nasopharyngeal carcinoma","volume":"30","author":"Chang","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0003","unstructured":"Ministry of Health. New cancer registrations 2017. Wellington; 2019. [cited 2022 Feb 20]. Available from: https:\/\/www.health.govt.nz\/publication\/new-cancer-registrations-2017"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2016.01.040","article-title":"Global trends in incidence and mortality of nasopharyngeal carcinoma","volume":"374","author":"Tang","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101702","article-title":"Rare cancers are not rare in Asia as well: the rare cancer burden in East Asia","volume":"67","author":"Matsuda","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0007","unstructured":"Statistics New Zealand. New Zealand's population reflects growing diversity 2019. 2019 [cited 2022 Apr 5]. Available from: https:\/\/www.stats.govt.nz\/news\/new-zealands-population-reflects-growing-diversity"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0008","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa1701717","article-title":"Analysis of plasma Epstein\u2013Barr virus DNA to screen for nasopharyngeal cancer","volume":"377","author":"Chan","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0009","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.oraloncology.2015.08.005","article-title":"Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for the treatment of nasopharyngeal carcinoma: a systematic review and meta-analysis","volume":"51","author":"Zhang","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0010","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejca.2016.12.039","article-title":"Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase III multicentre randomised controlled trial","volume":"75","author":"Cao","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0964-1955(95)00004-2","article-title":"Treasure E. Trends in oral cancer by subsite in New Zealand","volume":"31","author":"Cox","year":"1995","journal-title":"Eur J Cancer Part B Oral Oncol"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0013","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1440-1673.1990.tb02801.x","article-title":"Nasopharyngeal carcinoma in Auckland: a study of racial factors","volume":"34","author":"Morton","year":"1990","journal-title":"Australas Radiol"},{"issue":"5","key":"10.1016\/j.lanwpc.2022.100522_bib0014","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/1097-0347(200008)22:5<505::AID-HED10>3.0.CO;2-U","article-title":"Epstein Barr virus genome in nasopharyngeal carcinomas from New Zealand","volume":"22","author":"Popat","year":"2000","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.lanwpc.2022.100522_bib0015","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1445-2197.2009.05132.x","article-title":"Nasopharyngeal carcinoma: Differences in presentation between different ethnicities in the New Zealand setting","volume":"80","author":"Ianovski","year":"2010","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0016","unstructured":"Ministry of Health. New Zealand Cancer Registry [Internet]. 2019. Wellington; Available from: https:\/\/www.health.govt.nz\/nz-health-statistics\/national-collections-and-surveys\/collections\/new-zealand-cancer-registry-nzcr. Accessed 23 October 2019."},{"issue":"9","key":"10.1016\/j.lanwpc.2022.100522_bib0017","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjc.6603413","article-title":"Incidence rate trends of histological subtypes of nasopharyngeal carcinoma in Hong Kong","volume":"95","author":"Tse","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.lanwpc.2022.100522_bib0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/mdl320","article-title":"Epidemiology of nasopharyngeal carcinoma in the United States: Improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology","volume":"18","author":"Ou","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0019","unstructured":"American Cancer Society. Survival rates for nasopharyngeal cancer [Internet]. [cited 2022 Feb 20]. Available from: https:\/\/www.cancer.org\/cancer\/nasopharyngeal-cancer\/detection-diagnosis-staging\/survival-rates.html"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0020","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fonc.2019.01179","article-title":"Assessment of nasopharyngeal cancer in young patients aged \u2264 30 years","volume":"9","author":"Zhu","year":"2019","journal-title":"Front Oncol"},{"year":"2017","series-title":"HISO 10001: 2017. Ethnicity Data Protocols","key":"10.1016\/j.lanwpc.2022.100522_bib0021"},{"year":"2014","series-title":"NZDep2013 Index of Deprivation","author":"Atkinson","key":"10.1016\/j.lanwpc.2022.100522_bib0022"},{"year":"2017","series-title":"IDI Data Dictionary: Cancer Registrations Data","key":"10.1016\/j.lanwpc.2022.100522_bib0023"},{"year":"2003","series-title":"AJCC Cancer Staging Manual","author":"Schmoll","key":"10.1016\/j.lanwpc.2022.100522_bib0024"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0025","unstructured":"NZ Stats. 2006 Census [Internet]. Available from: http:\/\/nzdotstat.stats.govt.nz\/wbos\/index.aspx"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0026","first-page":"1","article-title":"Age standardization of rates: a new WHO standard","volume":"9","author":"Ahmad","year":"2001","journal-title":"GPE Discuss Pap Ser"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0027","first-page":"126","article-title":"Statistical methods for registries","volume":"95","author":"Boyle","year":"1991","journal-title":"Cancer Regist Princ Methods"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0028","unstructured":"StatsNZ. New Zealand cohort life tables: 2021 update [Internet]. [cited 2022 Feb 20]. Available from: https:\/\/www.stats.govt.nz\/information-releases\/new-zealand-cohort-life-tables-march-2021-update"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0029","first-page":"159","article-title":"Cancer registration: principles and methods. Analysis of survival","volume":"95","author":"Parkin","year":"1991","journal-title":"IARC Sci Publ"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0031","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cncr.32517","article-title":"Increasing incidence of Epstein\u2013Barr virus\u2013related nasopharyngeal carcinoma in the United States","volume":"126","author":"Argirion","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0032","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.oraloncology.2012.09.016","article-title":"Lower mortality from nasopharyngeal cancer in the Netherlands since 1970 with differential incidence trends in histopathology","volume":"49","author":"Arnold","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0033","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1158\/1055-9965.EPI-08-0461","article-title":"Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications","volume":"17","author":"Bray","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0034","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/0284186X.2017.1346378","article-title":"Outcome of nasopharyngeal carcinoma in Finland: a nationwide study","volume":"57","author":"Ruuskanen","year":"2018","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.oraloncology.2017.08.006","article-title":"Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: a population-based analysis","volume":"73","author":"Wu","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.lanwpc.2022.100522_bib0036","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","article-title":"Nasopharyngeal carcinoma: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Bossi","year":"2021","journal-title":"Ann Oncol"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522001377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522001377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T08:28:56Z","timestamp":1722155336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606522001377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":35,"alternative-id":["S2666606522001377"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100522","relation":{},"ISSN":["2666-6065"],"issn-type":[{"type":"print","value":"2666-6065"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100522","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100522"}}